Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
81
IQSM Quote, Financials, Valuation and Earnings
Last price:
$34.61
Seasonality move
:
6.53%
Day range:
$34.66 - $34.66
52-week range:
$26.78 - $35.44
Dividend yield:
1.2%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
133
Avg. volume:
7.8K
1-year change:
-1.28%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- |
|
CSD
Invesco S&P Spin-Off ETF
|
-- | -- | -- | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | -- | -- | -- | -- |
|
FNX
First Trust Mid Cap Core AlphaDEX Fund
|
-- | -- | -- | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- |
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
$34.66 | -- | -- | -- | $0.11 | 1.2% | -- |
|
CSD
Invesco S&P Spin-Off ETF
|
$100.82 | -- | -- | -- | $0.14 | 0.14% | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
$111.89 | -- | -- | -- | $1.32 | 1.18% | -- |
|
FNX
First Trust Mid Cap Core AlphaDEX Fund
|
$127.00 | -- | -- | -- | $0.19 | 0.93% | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
$109.30 | -- | -- | -- | $0.55 | 1.95% | -- |
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
$74.82 | -- | -- | -- | $0.88 | 1.18% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | 1.045 | -- | -- |
|
CSD
Invesco S&P Spin-Off ETF
|
-- | 1.621 | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | 0.706 | -- | -- |
|
FNX
First Trust Mid Cap Core AlphaDEX Fund
|
-- | 1.143 | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | 0.708 | -- | -- |
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | 0.665 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
CSD
Invesco S&P Spin-Off ETF
|
-- | -- | -- | -- | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | -- | -- | -- | -- | -- |
|
FNX
First Trust Mid Cap Core AlphaDEX Fund
|
-- | -- | -- | -- | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | -- | -- | -- | -- | -- |
NYLI Candriam US Mid Cap Equity ETF vs. Competitors
-
Which has Higher Returns IQSM or CSD?
Invesco S&P Spin-Off ETF has a net margin of -- compared to NYLI Candriam US Mid Cap Equity ETF's net margin of --. NYLI Candriam US Mid Cap Equity ETF's return on equity of -- beat Invesco S&P Spin-Off ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- CSDInvesco S&P Spin-Off ETF-- -- -- -
What do Analysts Say About IQSM or CSD?
NYLI Candriam US Mid Cap Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P Spin-Off ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Candriam US Mid Cap Equity ETF has higher upside potential than Invesco S&P Spin-Off ETF, analysts believe NYLI Candriam US Mid Cap Equity ETF is more attractive than Invesco S&P Spin-Off ETF.
Company Buy Ratings Hold Ratings Sell Ratings IQSMNYLI Candriam US Mid Cap Equity ETF0 0 0 CSDInvesco S&P Spin-Off ETF0 0 0 -
Is IQSM or CSD More Risky?
NYLI Candriam US Mid Cap Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco S&P Spin-Off ETF has a beta of 1.113, suggesting its more volatile than the S&P 500 by 11.286%.
-
Which is a Better Dividend Stock IQSM or CSD?
NYLI Candriam US Mid Cap Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 1.2%. Invesco S&P Spin-Off ETF offers a yield of 0.14% to investors and pays a quarterly dividend of $0.14 per share. NYLI Candriam US Mid Cap Equity ETF pays -- of its earnings as a dividend. Invesco S&P Spin-Off ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQSM or CSD?
NYLI Candriam US Mid Cap Equity ETF quarterly revenues are --, which are smaller than Invesco S&P Spin-Off ETF quarterly revenues of --. NYLI Candriam US Mid Cap Equity ETF's net income of -- is lower than Invesco S&P Spin-Off ETF's net income of --. Notably, NYLI Candriam US Mid Cap Equity ETF's price-to-earnings ratio is -- while Invesco S&P Spin-Off ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Candriam US Mid Cap Equity ETF is -- versus -- for Invesco S&P Spin-Off ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- -- CSDInvesco S&P Spin-Off ETF-- -- -- --
-
Which has Higher Returns IQSM or CZA?
Invesco Zacks Mid-Cap ETF has a net margin of -- compared to NYLI Candriam US Mid Cap Equity ETF's net margin of --. NYLI Candriam US Mid Cap Equity ETF's return on equity of -- beat Invesco Zacks Mid-Cap ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- CZAInvesco Zacks Mid-Cap ETF-- -- -- -
What do Analysts Say About IQSM or CZA?
NYLI Candriam US Mid Cap Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Zacks Mid-Cap ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Candriam US Mid Cap Equity ETF has higher upside potential than Invesco Zacks Mid-Cap ETF, analysts believe NYLI Candriam US Mid Cap Equity ETF is more attractive than Invesco Zacks Mid-Cap ETF.
Company Buy Ratings Hold Ratings Sell Ratings IQSMNYLI Candriam US Mid Cap Equity ETF0 0 0 CZAInvesco Zacks Mid-Cap ETF0 0 0 -
Is IQSM or CZA More Risky?
NYLI Candriam US Mid Cap Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Zacks Mid-Cap ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 12.032%.
-
Which is a Better Dividend Stock IQSM or CZA?
NYLI Candriam US Mid Cap Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 1.2%. Invesco Zacks Mid-Cap ETF offers a yield of 1.18% to investors and pays a quarterly dividend of $1.32 per share. NYLI Candriam US Mid Cap Equity ETF pays -- of its earnings as a dividend. Invesco Zacks Mid-Cap ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQSM or CZA?
NYLI Candriam US Mid Cap Equity ETF quarterly revenues are --, which are smaller than Invesco Zacks Mid-Cap ETF quarterly revenues of --. NYLI Candriam US Mid Cap Equity ETF's net income of -- is lower than Invesco Zacks Mid-Cap ETF's net income of --. Notably, NYLI Candriam US Mid Cap Equity ETF's price-to-earnings ratio is -- while Invesco Zacks Mid-Cap ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Candriam US Mid Cap Equity ETF is -- versus -- for Invesco Zacks Mid-Cap ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- -- CZAInvesco Zacks Mid-Cap ETF-- -- -- --
-
Which has Higher Returns IQSM or FNX?
First Trust Mid Cap Core AlphaDEX Fund has a net margin of -- compared to NYLI Candriam US Mid Cap Equity ETF's net margin of --. NYLI Candriam US Mid Cap Equity ETF's return on equity of -- beat First Trust Mid Cap Core AlphaDEX Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- FNXFirst Trust Mid Cap Core AlphaDEX Fund-- -- -- -
What do Analysts Say About IQSM or FNX?
NYLI Candriam US Mid Cap Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Mid Cap Core AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Candriam US Mid Cap Equity ETF has higher upside potential than First Trust Mid Cap Core AlphaDEX Fund, analysts believe NYLI Candriam US Mid Cap Equity ETF is more attractive than First Trust Mid Cap Core AlphaDEX Fund.
Company Buy Ratings Hold Ratings Sell Ratings IQSMNYLI Candriam US Mid Cap Equity ETF0 0 0 FNXFirst Trust Mid Cap Core AlphaDEX Fund0 0 0 -
Is IQSM or FNX More Risky?
NYLI Candriam US Mid Cap Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust Mid Cap Core AlphaDEX Fund has a beta of 1.106, suggesting its more volatile than the S&P 500 by 10.626%.
-
Which is a Better Dividend Stock IQSM or FNX?
NYLI Candriam US Mid Cap Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 1.2%. First Trust Mid Cap Core AlphaDEX Fund offers a yield of 0.93% to investors and pays a quarterly dividend of $0.19 per share. NYLI Candriam US Mid Cap Equity ETF pays -- of its earnings as a dividend. First Trust Mid Cap Core AlphaDEX Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQSM or FNX?
NYLI Candriam US Mid Cap Equity ETF quarterly revenues are --, which are smaller than First Trust Mid Cap Core AlphaDEX Fund quarterly revenues of --. NYLI Candriam US Mid Cap Equity ETF's net income of -- is lower than First Trust Mid Cap Core AlphaDEX Fund's net income of --. Notably, NYLI Candriam US Mid Cap Equity ETF's price-to-earnings ratio is -- while First Trust Mid Cap Core AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Candriam US Mid Cap Equity ETF is -- versus -- for First Trust Mid Cap Core AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- -- FNXFirst Trust Mid Cap Core AlphaDEX Fund-- -- -- --
-
Which has Higher Returns IQSM or JPME?
JPMorgan Diversified Return US Mid Cap Equity ETF has a net margin of -- compared to NYLI Candriam US Mid Cap Equity ETF's net margin of --. NYLI Candriam US Mid Cap Equity ETF's return on equity of -- beat JPMorgan Diversified Return US Mid Cap Equity ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- JPMEJPMorgan Diversified Return US Mid Cap Equity ETF-- -- -- -
What do Analysts Say About IQSM or JPME?
NYLI Candriam US Mid Cap Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Diversified Return US Mid Cap Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Candriam US Mid Cap Equity ETF has higher upside potential than JPMorgan Diversified Return US Mid Cap Equity ETF, analysts believe NYLI Candriam US Mid Cap Equity ETF is more attractive than JPMorgan Diversified Return US Mid Cap Equity ETF.
Company Buy Ratings Hold Ratings Sell Ratings IQSMNYLI Candriam US Mid Cap Equity ETF0 0 0 JPMEJPMorgan Diversified Return US Mid Cap Equity ETF0 0 0 -
Is IQSM or JPME More Risky?
NYLI Candriam US Mid Cap Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison JPMorgan Diversified Return US Mid Cap Equity ETF has a beta of 0.946, suggesting its less volatile than the S&P 500 by 5.437%.
-
Which is a Better Dividend Stock IQSM or JPME?
NYLI Candriam US Mid Cap Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 1.2%. JPMorgan Diversified Return US Mid Cap Equity ETF offers a yield of 1.95% to investors and pays a quarterly dividend of $0.55 per share. NYLI Candriam US Mid Cap Equity ETF pays -- of its earnings as a dividend. JPMorgan Diversified Return US Mid Cap Equity ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQSM or JPME?
NYLI Candriam US Mid Cap Equity ETF quarterly revenues are --, which are smaller than JPMorgan Diversified Return US Mid Cap Equity ETF quarterly revenues of --. NYLI Candriam US Mid Cap Equity ETF's net income of -- is lower than JPMorgan Diversified Return US Mid Cap Equity ETF's net income of --. Notably, NYLI Candriam US Mid Cap Equity ETF's price-to-earnings ratio is -- while JPMorgan Diversified Return US Mid Cap Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Candriam US Mid Cap Equity ETF is -- versus -- for JPMorgan Diversified Return US Mid Cap Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- -- JPMEJPMorgan Diversified Return US Mid Cap Equity ETF-- -- -- --
-
Which has Higher Returns IQSM or UPGD?
Invesco Bloomberg Analyst Rating Improvers ETF has a net margin of -- compared to NYLI Candriam US Mid Cap Equity ETF's net margin of --. NYLI Candriam US Mid Cap Equity ETF's return on equity of -- beat Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -
What do Analysts Say About IQSM or UPGD?
NYLI Candriam US Mid Cap Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Bloomberg Analyst Rating Improvers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Candriam US Mid Cap Equity ETF has higher upside potential than Invesco Bloomberg Analyst Rating Improvers ETF, analysts believe NYLI Candriam US Mid Cap Equity ETF is more attractive than Invesco Bloomberg Analyst Rating Improvers ETF.
Company Buy Ratings Hold Ratings Sell Ratings IQSMNYLI Candriam US Mid Cap Equity ETF0 0 0 UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 -
Is IQSM or UPGD More Risky?
NYLI Candriam US Mid Cap Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.944, suggesting its less volatile than the S&P 500 by 5.64%.
-
Which is a Better Dividend Stock IQSM or UPGD?
NYLI Candriam US Mid Cap Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 1.2%. Invesco Bloomberg Analyst Rating Improvers ETF offers a yield of 1.18% to investors and pays a quarterly dividend of $0.88 per share. NYLI Candriam US Mid Cap Equity ETF pays -- of its earnings as a dividend. Invesco Bloomberg Analyst Rating Improvers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQSM or UPGD?
NYLI Candriam US Mid Cap Equity ETF quarterly revenues are --, which are smaller than Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues of --. NYLI Candriam US Mid Cap Equity ETF's net income of -- is lower than Invesco Bloomberg Analyst Rating Improvers ETF's net income of --. Notably, NYLI Candriam US Mid Cap Equity ETF's price-to-earnings ratio is -- while Invesco Bloomberg Analyst Rating Improvers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Candriam US Mid Cap Equity ETF is -- versus -- for Invesco Bloomberg Analyst Rating Improvers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- -- UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
